Leerink Partnrs Has Negative Outlook of Veracyte Q1 Earnings
Veracyte, Inc. (NASDAQ:VCYT – Free Report) – Stock analysts at Leerink Partnrs decreased their Q1 2025 earnings per share estimates for shares of Veracyte in a research note issued to investors on Monday, April 21st. Leerink Partnrs analyst P. Souda now expects that the biotechnology company will post earnings per share of $0.08 for the […]
Veracyte, Inc. (NASDAQ:VCYT – Free Report) – Stock analysts at Leerink Partnrs decreased their Q1 2025 earnings per share estimates for shares of Veracyte in a research note issued to investors on Monday, April 21st. Leerink Partnrs analyst P. Souda now expects that the biotechnology company will post earnings per share of $0.08 for the […]
-logo.jpg?v=20210326142732&w=240&h=240&zc=2){kind=logo}
